← Eichor
Study identifier: NCT07406659 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Different Inspiratory Muscle Trainings in Patients With COPD

Condition: Chronic Obstructive Pulmonary Disease  ·  Sponsor: University of Yalova

PhaseNA
Planned participants51
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

COPD is one of the most life-threatening pulmonary diseases. According to the World Health Organization, it is expected to rise to the third leading cause of death by 2030. Smoking is the most significant contributing factor. COPD reduces lung volumes and causes dyspnea. Over time, respiratory muscle weakness develops, leading to hypercapnia, dyspnea, nocturnal oxygen desaturation, and decreased exercise performance. Pulmonary rehabilitation is the most important component of COPD treatment. Respiratory muscle training should be a mandatory component of the pulmonary rehabilitation program. Combining inspiratory muscle training with functional exercises allows the focus to be on respiratory muscle functions beyond the task of breathing. The purpose of this study was to investigate the effects of Functional Inspiratory Muscle Training on the course of the disease.

This description comes directly from the study's public registry record.

Talk to the study team

Erdi KAYABINAR, PhD  ·  +905077692025  ·  erdikayabinar@gmail.com

Gözde ACAR, MSc  ·  +905318893236  ·  gozde.arica@yalova.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Yalova UniversityYalova, Yalova, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07406659